AMEX:HTBX
Heat Biologics, Inc.
- Stock
Last Close
2.37
03/05 04:00
Market Cap
61.07M
Beta: 0.30
Volume Today
43.61K
Avg: 155.10K
PE Ratio
−1.69
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||
average payables | 1.01M - | 1.67M 65.77% | 1.14M 32.18% | 661.87K 41.69% | 1.00M 51.71% | 1.24M 23.39% | 1.28M 3.11% | 987.27K 22.72% | |
average receivables | 12.47K - | 41.15K - | 48.57K 18.02% | 21.69K 55.35% | 31.76K 46.47% | 106.11K 234.09% | 121.64K 14.64% | ||
book value per share | 125.87 - | 34.92 72.26% | 34.56 1.03% | 13.42 61.17% | 12.13 9.63% | 2.85 76.46% | 7.27 154.79% | 4.46 38.72% | |
capex per share | -4.91 - | -1.00 79.63% | -0.18 81.95% | -0.11 38.08% | -0.24 112.66% | -0.06 76.53% | -0.02 62.09% | ||
capex to depreciation | -6.86 - | -1 85.42% | -0.35 65.22% | -0.46 31.63% | -2.50 446.35% | -1.14 54.40% | -1.01 11.06% | ||
capex to operating cash flow | 0.05 - | 0.01 85.75% | 0.00 48.91% | 0.01 186.68% | 0.03 180.75% | 0.02 24.44% | 0.02 25.70% | ||
capex to revenue | -0.13 - | -0.04 69.96% | -0.10 153.68% | -0.09 15.11% | -0.11 31.82% | ||||
cash per share | 154.27 - | 100.24 35.02% | 30.81 69.26% | 17.77 42.32% | 11.10 37.55% | 3.10 72.04% | 6.99 125.37% | 0.32 95.42% | |
days of inventory on hand | |||||||||
days payables outstanding | |||||||||
days sales outstanding | 87.93 - | 3.56 95.95% | 1.80 49.53% | 4.19 132.95% | 21.94 423.98% | 11.41 48.00% | |||
debt to assets | 0.31 - | 0.81 164.32% | 0.23 71.50% | 0.71 208.71% | 0.20 72.09% | 0.49 147.59% | 0.07 85.79% | 0.07 5.35% | |
debt to equity | 0.42 - | 2.65 537.25% | 0.23 91.17% | 1.95 736.10% | 0.25 87.30% | 0.94 279.80% | 0.07 92.06% | 0.08 6.46% | |
dividend yield | |||||||||
earnings yield | -0.39 - | -1.02 160.79% | -0.83 19.41% | -0.80 2.56% | -0.92 14.17% | -1.27 37.90% | -0.30 75.99% | -0.46 52.34% | |
enterprise value | 29.02M - | 21.62M 25.48% | 7.39M 65.81% | 4.96M 32.89% | -5.02M 201.16% | 8.70M 273.30% | 76.58M 780.56% | 70.04M 8.55% | |
enterprise value over ebitda | -2.49 - | -1.09 56.19% | -0.62 43.04% | -0.40 36.24% | 0.30 176.83% | -0.44 244.70% | -2.98 575.91% | -1.97 33.84% | |
ev to operating cash flow | -2.95 - | -1.24 58.02% | -0.55 55.89% | -0.79 43.97% | 0.23 129.37% | -0.68 393.10% | -3.48 413.33% | ||
ev to sales | 21.64 - | 3.26 84.92% | -0.87 126.54% | 2.85 429.30% | 25.98 810.77% | 33.15 27.60% | |||
free cash flow per share | -110.12 - | -151.38 37.47% | -53.31 64.78% | -11.59 78.26% | -8.93 22.93% | -2.76 69.14% | -1.40 49.24% | ||
free cash flow yield | -0.34 - | -0.89 158.60% | -0.89 0.50% | -0.43 51.47% | -1.30 201.11% | -0.83 36.33% | -0.26 68.51% | ||
graham net net | 101.98 - | 7.82 92.33% | 22.97 193.86% | -8.44 136.72% | 8.10 195.97% | 0.42 94.85% | 6.46 1,449.58% | -0.03 100.51% | |
graham number | 597.79 - | 370.70 37.99% | 195.98 47.13% | 80.67 58.84% | 41.45 48.61% | 16.44 60.33% | 16.33 0.68% | 11.88 27.23% | |
income quality | 0.83 - | 0.86 3.10% | 1.08 25.11% | 0.53 50.51% | 1.38 159.23% | 0.64 53.53% | 0.85 31.82% | ||
intangibles to total assets | 0 - | 0 | 0 | 0.40 Infinity% | 0.21 46.54% | 0.28 32.18% | 0.06 79.10% | 0 100% | |
interest coverage | -166.14 - | -57.75 65.24% | -23.89 58.63% | ||||||
interest debt per share | 29.81 - | 61.28 105.59% | 2.16 96.48% | 0.06 - | 0.02 56.72% | 0.07 174.74% | |||
inventory turnover | |||||||||
invested capital | 0.23 - | 1.67 622.24% | 0.02 - | 0.00 83.01% | 0.01 348.34% | ||||
market cap | 30.02M - | 19.82M 33.99% | 15.23M 23.12% | 14.72M 3.35% | 17.14M 16.38% | 15.81M 7.74% | 85.67M 441.89% | 76.42M 10.80% | |
net current asset value | 10.39M - | 1.78M 82.91% | 6.21M 249.46% | -2.66M 142.91% | 21.19M 895.72% | 2.41M 88.63% | 105.09M 4,260.02% | 90.40M 13.98% | |
net debt to ebitda | 0.09 - | -0.09 205.88% | 0.66 823.55% | 0.78 18.27% | 1.34 72.33% | 0.36 73.20% | 0.35 1.96% | 0.18 49.17% | |
net income per share | -126.18 - | -174.92 38.63% | -49.40 71.76% | -21.56 56.36% | -6.30 70.78% | -4.21 33.16% | -1.63 61.29% | -1.41 13.60% | |
operating cash flow per share | -105.21 - | -150.38 42.93% | -53.13 64.67% | -11.48 78.40% | -8.69 24.25% | -2.70 68.94% | -1.38 48.97% | ||
payables turnover | |||||||||
receivables turnover | 4.15 - | 102.47 2,368.61% | 203.02 98.13% | 87.15 57.07% | 16.63 80.92% | 31.99 92.32% | |||
research and ddevelopement to revenue | 27.31 - | 5.44 80.08% | 2.80 48.49% | 4.27 52.33% | 4.39 2.84% | 8.91 102.96% | |||
return on tangible assets | -0.74 - | -1.54 107.30% | -1.41 7.95% | -0.98 30.95% | -0.53 45.73% | -1.07 102.79% | -0.22 79.25% | -0.29 31.31% | |
revenue per share | 1.34 - | 2.77 106.15% | 2.32 16.17% | 0.64 72.35% | 0.18 71.24% | 0.08 54.43% | |||
roe | -1.00 - | -5.01 399.78% | -1.43 71.47% | -1.61 12.39% | -0.52 67.67% | -1.47 183.95% | -0.22 84.81% | -0.32 41.00% | |
roic | -1.71 - | -15.48 804.42% | 1.85 111.98% | 33.82 1,723.85% | 2.25 93.33% | -3.26 244.69% | -0.26 92.09% | -0.34 31.58% | |
sales general and administrative to revenue | 12.11 - | 1.21 - | 3.09 155.09% | 5.09 64.52% | 7.96 56.52% | ||||
shareholders equity per share | 125.87 - | 34.92 72.26% | 34.56 1.03% | 13.42 61.17% | 12.13 9.63% | 2.85 76.46% | 7.27 154.79% | 4.46 38.72% | |
stock based compensation to revenue | 1.71 - | 0.45 73.41% | 0.14 69.98% | 1.07 687.86% | 2.16 101.74% | ||||
tangible asset value | 11.03M - | 2.50M 77.38% | 6.84M 174.15% | -2.27M 133.25% | 22.19M 1,075.52% | 5.84M 73.68% | 108.18M 1,752.48% | 112.03M 3.57% | |
tangible book value per share | 118.07 - | 21.50 81.79% | 26.87 24.95% | -4.14 115.41% | 8.88 314.53% | 1.23 86.17% | 6.77 451.08% | 4.46 34.15% | |
working capital | 12.71M - | 5.54M 56.41% | 6.67M 20.40% | 1.41M 78.87% | 23.84M 1,592.53% | 6.77M 71.59% | 110.14M 1,525.95% | 94.61M 14.10% |
All numbers in USD (except ratios and percentages)